Odd Erik Johansen
Position:	Associated Post doctoral researcher
Phone:
Email:

Scientific activities

Project:

The Asker and Baerum Cardiovascular Diabetes (ABCD) study

Supervisors:

Lars Gullestad and Kåre I. Birkeland

Aim:

In patients with type 2 diabetes to determine the prevalence of angiographically proven CAD, especially among asymptomatic patients, and ways to identify such patients and to examine how a structured multiinterventional approach in a hospital setting would influence individual CV risk factors and total CV risk burden compared to standard care.

Methods:

Structured organised care, analysis of inflammatory parameters, assessment of different non-invasive tests for coronary artery disease detection and coronary angiography.

Author network for Odd Erik Johansen by COREMINE medical

Publications in press

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI
Fetuin A in non-alcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol (in press)
PubMed 22170794

Johansen OE, Neubacher D, von Eynatten M, Patel S, Woerle HJ
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: A pre-specified, prospective, and adjudicated meta-analysis of a Phase 3 programme
Cardiovasc Diabetol, 11 (1), 3 (in press)
PubMed 22234149

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diab Vasc Dis Res (in press)
PubMed 22234949

Publications 2010

Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D (2010)
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus
Cardiovasc Diabetol, 9, 52
PubMed 20843304

Kontny F, Risanger T, Bye A, Arnesen Ø, Johansen OE, TELMIMORE Study Investigators (2010)
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care
Vasc Health Risk Manag, 6, 31-8
PubMed 20191081

Sørensen M, Johansen OE (2010)
Idiopathic reactive hypoglycaemia - prevalence and effect of fibre on glucose excursions
Scand J Clin Lab Invest, 70 (6), 385-91
PubMed 20509823

Publications 2009

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
PubMed 20923537

Johansen OE, Vanberg PJ, Kilhovd BK, Jørgensen AP (2009)
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Vasc Health Risk Manag, 5 (1), 121-8
PubMed 19436668

Publications 2008

Johansen OE (2008)
[Urogenital problems and female Internet users]
Tidsskr Nor Laegeforen, 128 (24), 2845-6
PubMed 19092957

Johansen OE, Bjurö T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L (2008)
Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes
Int J Cardiol, 127 (1), 129-32
PubMed 17532067

Johansen OE, Brustad E, Enger S, Tveit A (2008)
Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects
Cardiovasc Diabetol, 7, 28
PubMed 18822173

Johansen OE, Qvigstad E (2008)
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg
Adv Ther, 25 (6), 525-51
PubMed 18568306

Johansen OE, Whitfield R (2008)
Exenatide may aggravate moderate diabetic renal impairment: a case report
Br J Clin Pharmacol, 66 (4), 568-9
PubMed 18537959

Publications 2007

Johansen OE (2007)
[Natural preparations against climacteric problems?]
Tidsskr Nor Laegeforen, 127 (6), 764-5
PubMed 17363992

Johansen OE (2007)
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis
Scand J Clin Lab Invest, 67 (8), 786-800
PubMed 17852797

Johansen OE, Birkeland KI (2007)
Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review
Am J Cardiovasc Drugs, 7 (5), 319-35
PubMed 17953471

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
PubMed 17454845

Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI (2007)
Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial
Diabet Med, 24 (9), 1019-27
PubMed 17509068

Publications 2006

Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
Eur J Clin Invest, 36 (8), 544-51
PubMed 16893376

Johansen OE, Jørgensen AP (2006)
[Glitazone treatment of type 2 diabetes mellitus]
Tidsskr Nor Laegeforen, 126 (15), 1928-30
PubMed 16915317

Starkopf J, Hegna S, Johansen OE, Munch-Ellingsen J, Mjøs OD, Ytrehus K (2006)
In vivo chronic carvedilol treatment in rats attenuates ex vivo regional infarction of the heart
Scand Cardiovasc J, 40 (4), 240-7
PubMed 16914417

Publications 2005

Johansen OE, Birkeland KI (2005)
[Misleading about insulin administration to patients with diabetes]
Tidsskr Nor Laegeforen, 125 (16), 2247; author reply 2247
PubMed 16138161

Publications 2003

Johansen OE, Birkeland KI (2003)
Preventing macrovascular disease in patients with type 2 diabetes mellitus
Am J Cardiovasc Drugs, 3 (4), 283-97
PubMed 14728081

[913 visits]

Go back

Print this page

E-mail this page